AU5840300A - Glutx polypeptide family and nucleic acids encoding same - Google Patents

Glutx polypeptide family and nucleic acids encoding same

Info

Publication number
AU5840300A
AU5840300A AU58403/00A AU5840300A AU5840300A AU 5840300 A AU5840300 A AU 5840300A AU 58403/00 A AU58403/00 A AU 58403/00A AU 5840300 A AU5840300 A AU 5840300A AU 5840300 A AU5840300 A AU 5840300A
Authority
AU
Australia
Prior art keywords
glutx
nucleic acids
acids encoding
encoding same
polypeptide family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58403/00A
Inventor
Mark Ibberson
Bernard Thorens
Marc Uldry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Lausanne
Original Assignee
Universite de Lausanne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Lausanne filed Critical Universite de Lausanne
Publication of AU5840300A publication Critical patent/AU5840300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU58403/00A 1999-07-14 2000-07-14 Glutx polypeptide family and nucleic acids encoding same Abandoned AU5840300A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US14390799P 1999-07-14 1999-07-14
US60143907 1999-07-14
US15114099P 1999-08-27 1999-08-27
US60151140 1999-08-27
US18428500P 2000-02-23 2000-02-23
US60184285 2000-02-23
US61613200A 2000-07-13 2000-07-13
US09616132 2000-07-13
PCT/IB2000/001042 WO2001004145A2 (en) 1999-07-14 2000-07-14 Glutx polypeptide family and nucleic acids encoding same

Publications (1)

Publication Number Publication Date
AU5840300A true AU5840300A (en) 2001-01-30

Family

ID=27495594

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58403/00A Abandoned AU5840300A (en) 1999-07-14 2000-07-14 Glutx polypeptide family and nucleic acids encoding same

Country Status (2)

Country Link
AU (1) AU5840300A (en)
WO (1) WO2001004145A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001735B2 (en) 2000-03-01 2006-02-21 Albert Einstein College Of Medicine Of Yeshiva University Glucose transporter/sensor protein and uses thereof
ATE483976T1 (en) * 2001-06-05 2010-10-15 Exelixis Inc GFATS AS P53 PATHWAY MODIFIERS AND METHODS OF USE
DE10305212A1 (en) * 2003-02-07 2004-08-19 Florian Prof. Dr.med. Lang Use of the sgk gene family for the diagnosis and therapy of cataracts and glaucoma
AU2005318836B2 (en) * 2004-12-21 2012-03-22 Viventia Bio Inc. Cancer specific antibody and cell surface proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942398A (en) * 1998-02-26 1999-08-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding glutx and uses thereof
WO1999059559A1 (en) * 1998-05-15 1999-11-25 Joslin Diabetes Center Independent regulation of basal and insulin-stimulated glucose transport

Also Published As

Publication number Publication date
WO2001004145A2 (en) 2001-01-18
WO2001004145A3 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
WO1999046281A8 (en) Novel polypeptides and nucleic acids encoding the same
AU2002214531A1 (en) Proteins and nucleic acids encoding same
AU1222901A (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU2001288390A1 (en) Proteins and nucleic acids encoding same
AU1909900A (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
AU2001239889A1 (en) Polypeptides and nucleic acids encoding same
WO2002094870A8 (en) Proteins and nucleic acids encoding same
AU3511100A (en) Novel nucleic acids and polypeptides
AU5840300A (en) Glutx polypeptide family and nucleic acids encoding same
AU2001239756A1 (en) Novel proteins and nucleic acids encoding same
AU1453601A (en) Novel polypeptides and nucleic acids encoding same
AU2002211681A1 (en) Proteins and nucleic acids encoding same
AU1486801A (en) Novel growth factor polypeptides and nucleic acids encoding same
AU7756100A (en) Interleukin-2 like protein and nucleic acids encoding same
AU2002227445A1 (en) Proteins and nucleic acids encoding same
AU2001234896A1 (en) Novel polypeptides and nucleic acids encoding same
AU2002313838A1 (en) Novel PRO866 polypeptides and nucleic acids encoding same
AU2278001A (en) Novel polypeptides and nucleic acids encoding same
AU1103301A (en) Pdgf-associated proteins and nucleic acids encoding the same
WO2002032961A8 (en) Novel polypeptides and nucleic acids encoding same
AU2001234627A1 (en) Novel polypeptides and nucleic acids encoding same
AU2002317529A1 (en) Novel PRO618 polypeptides and nucleic acids encoding same
AU2002301608A1 (en) Novel PRO351 Polypeptides and Nucleic Acids Encoding Same
AU2002318894A2 (en) Novel PR0474 polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase